Go team.
“The training process was smooth and easy across individuals from a range of clinical fields of expertise. Training was completed in less than a day and the team is excited to undertake the clinical trial. Usability is at the heart of our device, and this was evident in the training. We are thrilled to start the next phase of our journey and are grateful for the support of our clinical collaborators”
Ann: EMVision Commences Clinical Trial, page-2
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.00 |
Change
-0.060(2.91%) |
Mkt cap ! $171.0M | |||
| Open | High | Low | Value | Volume |
| $2.05 | $2.13 | $1.99 | $251.9K | 123.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9762 | $2.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.06 | 2346 | 1 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| EMV (ASX) Chart |